论文部分内容阅读
目的探讨米力农治疗慢性肺心病合并心力衰竭的临床疗效。方法回顾分析30例患者的临床资料。结果 35例经米力农治疗后,显效7例,有效25例;治疗前后患者的血尿常规、肝肾功能及电解质无明显变化;其中1例死于严重感染合并Ⅱ型呼吸衰竭,1例出现频发房性期前收缩,1例出现频发室性期前收缩二三联律,经减慢泵入速度后,未给予特殊处理逐渐好转。结论慢性肺心病合并心力衰竭患者应用米力农治疗疗效满意,值得临床应用。
Objective To investigate the clinical efficacy of milrinone in the treatment of chronic pulmonary heart disease complicated with heart failure. Methods The clinical data of 30 patients were retrospectively analyzed. Results 35 cases were treated with Milrinone, 7 cases were effective and 25 cases were effective. The hematuria routine, liver and kidney function and electrolytes did not change before and after treatment. One case died of severe infection with type Ⅱ respiratory failure, and one case appeared Frequent paroxysmal atrial contraction, a case of frequent occurrence of ventricular contractions before and after two or three law, after slowing down into the pump speed, no special treatment gradually improved. Conclusion Chronic pulmonary heart disease patients with heart failure with Milrinone treatment satisfactory results, it is worth clinical application.